Foresite Capital Management III’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $13.8M | Hold |
133,691
| – | – | 36.44% | 1 |
|
|
2022
Q2 | $12.4M | Hold |
133,691
| – | – | 45.08% | 1 |
|
|
2022
Q1 | $15.7M | Hold |
133,691
| – | – | 47.81% | 1 |
|
|
2021
Q4 | $18M | Buy |
+133,691
| New | +$18M | 45.53% | 1 |
|
|
2020
Q1 | – | Sell |
-13,922
| Closed | -$1.94M | – | 10 |
|
|
2019
Q4 | $1.94M | Sell |
13,922
-190,166
| -93% | -$26.5M | 1.09% | 10 |
|
|
2019
Q3 | $19.7M | Hold |
204,088
| – | – | 7.51% | 5 |
|
|
2019
Q2 | $23.5M | Hold |
204,088
| – | – | 7.71% | 5 |
|
|
2019
Q1 | $24M | Hold |
204,088
| – | – | 6.25% | 5 |
|
|
2018
Q4 | $12.8M | Buy |
204,088
+12,500
| +7% | +$783K | 4.2% | 8 |
|
|
2018
Q3 | $13.6M | Hold |
191,588
| – | – | 3% | 10 |
|
|
2018
Q2 | $12.7M | Sell |
191,588
-110,421
| -37% | -$7.34M | 2.74% | 12 |
|
|
2018
Q1 | $19.8M | Sell |
302,009
-34,255
| -10% | -$2.24M | 4.3% | 9 |
|
|
2017
Q4 | $13.5M | Buy |
336,264
+51,121
| +18% | +$2.05M | 3.78% | 7 |
|
|
2017
Q3 | $10.3M | Buy |
285,143
+262,743
| +1,173% | +$9.52M | 2.85% | 11 |
|
|
2017
Q2 | $622K | Sell |
22,400
-77,600
| -78% | -$2.15M | 0.2% | 23 |
|
|
2017
Q1 | $2.8M | Sell |
100,000
-80,000
| -44% | -$2.24M | 1.07% | 15 |
|
|
2016
Q4 | $3.64M | Buy |
+180,000
| New | +$3.64M | 1.58% | 14 |
|